MGRX · Mangoceuticals, Inc. · Documents
$0.30
0.00 (-0.07%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the 12 months from the date of issuance of this filing.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.47M
Shares
21.57M
Volume · Oct 20
178.27K
Avg daily vol (3M)
12.64M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-11-07 | 2023-11-03 | |
| 8-K | — | 2023-11-01 | 2023-10-30 | |
| 10-Q | — | 2023-10-27 | 2023-09-30 | |
| 8-K | — | 2023-10-19 | — | |
| 8-K | — | 2023-10-04 | 2023-10-03 | |
| 8-K | — | 2023-09-21 | 2023-09-15 | |
| 8-K | — | 2023-09-08 | 2023-09-01 | |
| 10-Q | — | 2023-07-28 | 2023-06-30 | |
| 8-K | — | 2023-06-23 | 2023-06-21 | |
| 10-Q | — | 2023-05-10 | 2023-03-31 | |
| 8-K | — | 2023-05-04 | 2023-05-01 | |
| S-1/A | — | 2023-02-28 | — | |
| S-1/A | — | 2023-02-21 | — | |
| S-1/A | — | 2023-02-06 | — | |
| S-1/A | — | 2023-01-26 | — | |
| S-1 | — | 2023-01-13 | — |
Showing 101–116 of 116 filings